Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)
Clinical trial NCT03400033 · COMPLETED
Trial details
- NCT number
- NCT03400033
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2020-06-19
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.